PRF Technologies (PRFX) Accounts Payables (2019 - 2025)
PRF Technologies (PRFX) recorded quarterly Accounts Payables of $213000.0 in Q4 2025, up 261.36% on a QoQ basis from -$132000.0 in Q2 2025, and down 28.04% year-over-year from $296000.0 in Q4 2024.
PRF Technologies (PRFX) Accounts Payables (2019 - 2025) Analysis & Trends
PRF Technologies has disclosed Accounts Payables across 7 years of filings, most recently posting $213000.0 for Q4 2025.
- Quarterly Accounts Payables fell 28.04% year-over-year to $213000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (down 28.04% YoY) and the FY2025 annual result came in at $213000.0, down 28.04% from the prior year.
- Accounts Payables grew to $213000.0 in Q4 2025, from -$132000.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $313000.0 in Q1 2023 and troughed at -$561000.0 in Q1 2021.
- A 5-year average of $39411.8 and a median of $70000.0 in 2023 frame the typical range for Accounts Payables.
- Biggest YoY gain for Accounts Payables was 338.46% in 2021; the steepest drop was 2539.13% in 2021.
- Tracing PRFX's Accounts Payables over 5 years: stood at $136000.0 in 2021, then soared by 53.68% to $209000.0 in 2022, then plunged by 66.99% to $69000.0 in 2023, then jumped by 328.99% to $296000.0 in 2024, then slipped by 28.04% to $213000.0 in 2025.
- Business Quant data shows PRFX's Accounts Payables at $213000.0 in Q4 2025, -$132000.0 in Q2 2025, and $296000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | 213,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 213,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Dec 31, 2024 | 296,000.00 |
| Jun 30, 2024 | -102,000.00 |
| Mar 31, 2024 | -12,000.00 |
| Dec 31, 2023 | 69,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 70,000.00 |
| Mar 31, 2023 | 313,000.00 |
| Dec 31, 2022 | 209,000.00 |
| Sep 30, 2022 | 249,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | 136,000.00 |
| Sep 30, 2021 | -550,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | -561,000.00 |
| Dec 31, 2020 | 720,000.00 |
| Sep 30, 2020 | 1.04 Mn |
| Jun 30, 2020 | 13,000.00 |